Rita, Indo-Pacific bottlenose dolphin at Hong Kong's Ocean Park, dies at 24

A 24-year-old Indo-Pacific bottlenose dolphin named Rita has died at Hong Kong's Ocean Park after showing signs of fatigue and a loss of appetite.
The marine mammal had lived in the park for about 13 years after she was transferred from Tunisia. Investigations into her death are ongoing.
'Rita was a playful animal who got along well with her dolphin and human mates, and was a beloved animal ambassador living in the Marine Mammal Breeding and Research Centre next to the Ocean Park Veterinary Centre,' a park spokesman said.
Do you have questions about the biggest topics and trends from around the world? Get the answers with SCMP Knowledge, our new platform of curated content with explainers, FAQs, analyses and infographics brought to you by our award-winning team.
She had refused to eat and showed signs of tiredness since Friday.
The park said that veterinarians performed thorough examinations and blood tests on the dolphin, which caretakers looked after around the clock.
But her health conditions worsened and she died on Sunday afternoon.
The park has conducted a necropsy to determine the cause of death, while further laboratory tests are under way.
The spokesman said that students had learned about and appreciated the natural behaviour and daily care of dolphins up close through guided tours, and were inspired to contribute to marine conservation.
'The park expresses its gratitude to Rita for conveying conservation messages to visitors. She will forever hold a special place in our hearts and memories,' he said.
Rita was transferred to Hong Kong from Friguia Park in Tunisia in November 2012, after the facility closed its dolphin show, according to Ceta-Base, an online database of captive-held cetaceans across the world.
She gave birth to a male calf named Rati in September 2015.
In 2021, Ocean Park announced that Milo, a seven-year-old female Indo-Pacific bottlenose dolphin, died after suffering acute haemorrhagic enteritis, or inflammation of the intestines.
More from South China Morning Post:
For the latest news from the South China Morning Post download our mobile app. Copyright 2025.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

New Straits Times

04-06-2025

• New Straits Times

#SHOWBIZ: 24-year-old Taiwanese influencer known for eating cosmetics dies

TAIPEI: In a tragic turn of events, Guava Beauty, a 24-year-old Taiwanese influencer known for eating beauty products or "make-up mukbang" videos, has died suddenly. Her death on May 24 has sparked widespread speculation on mainland Chinese social media, with many suggesting poisoning as a possible cause, the South China Morning Post reported. Her family announced the news of her passing in a statement posted on her social media account. It read: "It is with deep sorrow that we inform you that our treasured girl of beauty-product mukbangs, Guava Beauty, put down her brushes and flew off to start a new channel in heaven on May 24, 2025." "Thank you to everyone who ever liked, commented, and laughed with her. She truly cherished it all." The statement ended with, "Maybe when we meet again, she will be unboxing angel-exclusive make-up for her celestial mukbang." Guava Beauty, who had amassed over 12,000 followers on one social media platform, captivated her audience with a sweet, youthful image and creative content. Her signature videos featured her attempting to consume various beauty products, including lipstick, blush, face masks, and cotton pads. In a recent promotional clip for a jelly-like blush, she famously declared, "If you dare recommend it, I dare to eat it." The video showed her applying the blush before using a fork to eat it, describing it as "crispy, kind of like agar jelly," but ultimately, "terrible." While many fans were shocked by her content, others expressed concern that her videos might mislead viewers, particularly younger audiences, into believing that cosmetics were safe for consumption. The news of her death sent shockwaves across both mainland China and Taiwan, as evidenced by one user who commented, "I cannot believe it, but I know Guava Beauty will be the most beautiful beauty-mukbang angel in heaven." Mukbang (meaning eating broadcast) content is hugely popular in China and many other Asian countries.

Malaysian Reserve

31-05-2025

• Malaysian Reserve

Illuminating ctDNA-MRD: Gene Solutions' K-CONNECT APAC 2025 Sparks Regional Collaboration in Precision Oncology

DA NANG, Vietnam, May 31, 2025 /PRNewswire/ — May 9-11, 2025, Gene Solutions, a pioneer in AI-driven precision oncology hosted K-CONNECT APAC 2025, a pivotal summit uniting over 100 distinguished oncologists and molecular biologists from nine Asia-Pacific countries. — This landmark event marked a significant milestone in advancing precision oncology, fostering collaboration, and driving innovation in the fields of circulating tumor DNA (ctDNA), Molecular Residual Disease (MRD), and Comprehensive Genomic Profiling (CGP). Under the theme 'Empowering the Potential of ctDNA-MRD,' 16 distinguished speakers and panelists shared clinical insights, breakthrough research, and innovative strategies for integrating ctDNA-MRD into cancer practice. 'While ctDNA and MRD are invisible to the eye, K-CONNECT APAC 2025 shed transformative light on their potential through regional collaboration and clinical innovation,' said Ida Deleskog Lindstrom, Global Medical Affairs Director at Gene Solutions. 'Illuminating ctDNA-MRD means revealing actionable insights that spark hope, clarity, and progress through molecular insights to transform precision oncology.' 'K-CONNECT APAC 2025 was a transformative moment for precision oncology in the Asia-Pacific, bringing together diverse expertise to translate ctDNA-MRD advancements into real-world clinical impact' said Professor Nick Pavlakis, Co-Chair of the summit and a leading medical oncologist from Australia. 'This summit has set a new benchmark for collaborative innovation, paving the way for personalized cancer care across the region' A First-of-Its-Kind Gathering in Asia-Pacific Gene Solutions, a regional pioneer in ctDNA-MRD testing, has supported over 6,000 cancer patients via its next generation comprehensive AI-powered K-TRACK® and K-4CARE® platforms. K-CONNECT APAC 2025 showcased its role in fostering cross-border expertise to accelerate adoption of precision diagnostics. The summit featured three key sessions shared by 16 esteemed experts K-CONNECT ACADEMIC Session: The Importance of ctDNA-MRD and CGP in Precision Oncology Unique Combination of Genomic & Transcriptomic Profiling with ctDNA-MRD Monitoring Key findings from Asia's First Real-World Study of ctDNA-MRD Monitoring in Solid Tumors. K-CONNECT CASE SHARING Session ctDNA-MRD Applications & Real-World Case Sharing in Colorectal, Lung and Breast cancers. K-CONNECT NEXT LANDMARK Session Genetic Testing Guided Personalized Immunotherapy in Refractory Solid Tumors. Triad of Impact– A Multi-omic Solution to Advance Precision Oncology Innovation. Beyond an Event — Establishing a Platform for Ongoing Impact K-CONNECT is evolving into a regional hub for knowledge exchange, clinical collaborations, and precision oncology innovation acceleration. Upcoming initiatives include: K-CONNECT Webinar Series – Ongoing expert-led case discussions Clinical Trials Collaboration – Cross-border partnerships with biopharma and research institutions Experience ctDNA-MRD Program – Hands-on implementation support for clinicians Knowledge Hub – A digital platform for APAC oncology insights Shaping the Future of Cancer Care K-CONNECT APAC 2025 solidified Gene Solutions' leadership in genetic testing and its commitment to advancing equitable access to innovative solutions to improve patient outcomes. By fostering collaboration and showcasing real-world impact, the summit laid the foundation for a more connected, data-driven, and patient-centered future in cancer care across the Asia-Pacific. About Gene Solutions Gene Solutions is a leading multinational biotechnology company headquartered in Asia, pioneering the integration of advanced AI and circulating tumor DNA (ctDNA) technologies to deliver innovative solutions across the cancer care continuum. Recognized for its proprietary research and CAP-accredited laboratories, the company combines multi-dimensional genomics with AI-driven analytics to transform oncology—from early detection to real-time treatment monitoring. With a strong regional presence and a commitment to empowering access to precision medicine, Gene Solutions is shaping the future of cancer diagnostics and personalized care across the Asia-Pacific. Explore more information at: MEDIA CONTACT: pr@

The Sun

30-05-2025

• The Sun

Humansa and i-Cognitio Sciences Unveil the World's First AI-Powered Retinal Imaging for Alzheimer's Risk Detection

HONG KONG SAR - Media OutReach Newswire - 29 May 2025 - Humansa, Asia's leading health and longevity center, is proud to announce the launch of its ground-breaking BrainSpark Program, a brain health program in collaboration with i-Cognitio Sciences, a spin-off company from the Chinese University of Hong Kong (CUHK) founded by Prof. Vincent Mok. This revolutionary program incorporates the world's first artificial intelligence (AI) model capable of detecting risk of Alzheimer's disease using fundus photographs alone, offering a non-invasive and accessible solution to address the growing global challenge of cognitive decline and dementia. The Humansa BrainSpark Program is a timely response to the alarming statistics in developed Asia-Pacific regions, where the mean life expectancy has reached 85 years. Yet, 1 in 3 individuals aged 85 or above may suffer from dementia, a devastating disease that robs individuals of their independence and quality of life. Research shows that 45% of dementia cases can be prevented or delayed by optimizing modifiable risk factors, making early detection and personalized interventions critical. A Revolutionary Approach to Brain Health The Humansa BrainSpark Program embodies a proactive approach to brain health by offering: Comprehensive Brain Health Assessment: Powered by state-of-the-art AI retinal imaging technology (i-Cog Brain Health) led and developed by Prof. Vincent Mok's team, the program evaluates brain health and identifies early signals of Alzheimer's disease. The AI model, developed and validated using nearly 13,000 fundus photographs from 648 Alzheimer's patients and 3,240 cognitively normal subjects, demonstrated accuracies ranging from 80% to 92% among various datasets of multi-ethnicities and multi-countries. The study was led by CUHK in collaboration with Universities in Singapore (National University of Singapore, Duke-National University, Nanyang Technological University), China (Tsinghua University), US (Mayo Clinic) and UK (Queen's University Belfast). The findings were published in the prestigious Lancet Digital Health journal in 2022. Tailor-Made Lifestyle Solutions: The Humansa BrainSpark Program offers tailor-made solutions that go beyond standard care, focusing on early detection and prevention of major chronic diseases, including Alzheimer's and dementia. By combining advanced AI technology with personalized care, Humansa provides lifestyle interventions, medical support, and preventive strategies tailored to each individual's unique risk profile. Additionally, Humansa's signature membership program offers a holistic anti-aging solution. This comprehensive package includes personalized recommendations on supplements, the frequency of restorative therapies, and other longevity strategies, empowering individuals to take proactive steps toward better brain health and overall well-being. Professor Vincent Mok, Founding Director of i-Cognitio Sciences and Mok Hing Yiu Professor of Medicine of CUHK explains, 'The retina is an extension of the brain, and through non-invasive fundus photography, we can detect changes in the blood vessels and nerves of the retina that are associated with Alzheimer's disease. These changes can appear 10–15 years before symptoms develop, giving us a critical window for early intervention. This AI model can identify early microvascular changes associated with Alzheimer's disease that may not be detected even by conventional MRI, making it a powerful tool for identifying high-risk cases in both clinical and community settings.' Regarding the Humansa BrainSpark Program, Professor Mok adds, 'This program is an innovative initiative that combines cutting-edge AI technology with personalized care approach. It encourages individuals to take proactive steps to protect their brain health, enabling early preventive treatments and lifestyle changes that can slow cognitive decline and preserve quality of life.' Aligning with Humansa's Methodology to Longevity The newly launched Humansa BrainSpark Program is a cornerstone of Humansa's methodology to longevity and its signature Future Health Program, which emphasizes prevention, early detection, and personalized care. Cognitive function is a critical pillar of Humansa's longevity strategy, as maintaining brain health is essential for living a long, independent, and fulfilling life. Don So, CEO of Humansa, shares, 'At Humansa, we believe that aging is not a passive process—it's a skill, a choice, and a science. Cognitive function is at the heart of our longevity strategy because it directly impacts an individual's ability to live independently and enjoy life to the fullest. The symptoms may show up decades later, but the seeds are often planted much earlier. The silent inflammation, the unchecked insulin resistance, and the daily choices—small and seemingly insignificant—that quietly shape your destiny. The Brain Health Program is a testament to our commitment to empowering individuals to live longer, healthier lives by providing them with the tools and knowledge to protect their brain health.' A Call to Action The Humansa BrainSpark Program combines cutting-edge technology with personalized care, offering individuals a proactive way to protect their brain health and live longer, healthier lives.